Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats

Yoshito Kumagai, Lena Y. Lin, Akira Hiratsuka, Shizuo Narimatsu, Tokuji Suzuki, Hideyuki Yamada, Kazuta Oguri, Hidetoshi Yoshimura, Arthur K. Cho

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.

Original languageEnglish
Pages (from-to)359-365
Number of pages7
JournalMolecular Pharmacology
Volume45
Issue number2
Publication statusPublished - Feb 1994
Externally publishedYes

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Phenobarbital
Cytochrome P-450 Enzyme System
Isoenzymes
Liver Microsomes
Pregnenolone Carbonitrile
Microsomes
Sprague Dawley Rats
Sparteine
Cytochrome P-450 CYP2B1
Cytochromes b5
Desipramine
Methylcholanthrene
Antibodies
Protein Isoforms
Immunoglobulin G

ASJC Scopus subject areas

  • Pharmacology

Cite this

Kumagai, Y., Lin, L. Y., Hiratsuka, A., Narimatsu, S., Suzuki, T., Yamada, H., ... Cho, A. K. (1994). Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. Molecular Pharmacology, 45(2), 359-365.

Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. / Kumagai, Yoshito; Lin, Lena Y.; Hiratsuka, Akira; Narimatsu, Shizuo; Suzuki, Tokuji; Yamada, Hideyuki; Oguri, Kazuta; Yoshimura, Hidetoshi; Cho, Arthur K.

In: Molecular Pharmacology, Vol. 45, No. 2, 02.1994, p. 359-365.

Research output: Contribution to journalArticle

Kumagai, Y, Lin, LY, Hiratsuka, A, Narimatsu, S, Suzuki, T, Yamada, H, Oguri, K, Yoshimura, H & Cho, AK 1994, 'Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats', Molecular Pharmacology, vol. 45, no. 2, pp. 359-365.
Kumagai, Yoshito ; Lin, Lena Y. ; Hiratsuka, Akira ; Narimatsu, Shizuo ; Suzuki, Tokuji ; Yamada, Hideyuki ; Oguri, Kazuta ; Yoshimura, Hidetoshi ; Cho, Arthur K. / Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. In: Molecular Pharmacology. 1994 ; Vol. 45, No. 2. pp. 359-365.
@article{9d1a973343d04be89bb9423a9e78a5ff,
title = "Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats",
abstract = "The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9{\%} of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.",
author = "Yoshito Kumagai and Lin, {Lena Y.} and Akira Hiratsuka and Shizuo Narimatsu and Tokuji Suzuki and Hideyuki Yamada and Kazuta Oguri and Hidetoshi Yoshimura and Cho, {Arthur K.}",
year = "1994",
month = "2",
language = "English",
volume = "45",
pages = "359--365",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats

AU - Kumagai, Yoshito

AU - Lin, Lena Y.

AU - Hiratsuka, Akira

AU - Narimatsu, Shizuo

AU - Suzuki, Tokuji

AU - Yamada, Hideyuki

AU - Oguri, Kazuta

AU - Yoshimura, Hidetoshi

AU - Cho, Arthur K.

PY - 1994/2

Y1 - 1994/2

N2 - The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.

AB - The cytochrome P450 isozymes in rat liver microsomes that catalyze the demethylenation of methylenedioxymethamphetamine enantiomers to the corresponding dihydroxymethamphetamine were characterized. Dihydroxymethamphetamine formation in liver microsomes from male Sprague- Dawley rats exhibited multienzyme kinetics, with K(m) values in the micromolar/millimolar range. The stereoselectivity [(+)-isomer versus (-)- isomer] varied from 0.78 to 1.94 after pretreatment of the rats with phenobarbital, 3-methylcholanthrene, pregnenolone-16α-carbonitrile, or pyrazole, suggesting that different isozymes participate in the reaction. The low-K(m) demethylenation was not induced by these compounds and was not inhibited by antibodies raised against CYP2C11. Liver microsomes from female Dark-Agouti rats, a strain genetically deficient in CYP2D1, exhibited demethylenation activities that were 9% of those in microsomes from male Sprague-Dawley rats. The low-K(m) demethylenation was also inhibited by CYP2D substrates such as sparteine, bufuralol, or desipramine and was almost completely inhibited by antibodies against P450 BTL, which belongs to the CYP2D family. The high-K(m) demethylenation activity was induced by phenobarbital and pregnenolone-16α-carbonitrile and the activity in both untreated and phenobarbital-induced microsomes was suppressed by anti-CYP2B1 IgG. Experiments with IgG raised against cytochrome b5 suggested that the hemoprotein contributed to the low-K(m) activity but not the high-K(m) activity. These results indicate that cytochrome P450 isozymes belonging to the CYP2D subfamily catalyze demethylenation with low K(m) values and that the reaction occurring with high K(m) values is likely to be mediated by members of the CYP2B family, but with the possible participation of other phenobarbital-inducible isoforms.

UR - http://www.scopus.com/inward/record.url?scp=0028069445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028069445&partnerID=8YFLogxK

M3 - Article

C2 - 7906857

AN - SCOPUS:0028069445

VL - 45

SP - 359

EP - 365

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -